Applications of 3-(2,6-Dichlorophenyl)-5-Methylisoxazole-4-Carbonyl Chloride in Industrial Manufacturing

3-(2,6-Dichlorophenyl)-5-Methylisoxazole-4-Carbonyl Chloride is widely adopted as a critical intermediate within select industrial synthesis chains, supporting advanced pharmaceutical and agrochemical development. Below, we detail key downstream application scenarios, referencing real compliance, formulation practice, process entry points, and end products as realized by our direct bulk buyers and partners.

1. Nonsteroidal Anti-Inflammatory Drug (NSAID) Active Ingredient Synthesis

This intermediate is primarily used in the manufacture of specific isoxazole-based NSAIDs, especially those requiring a dichlorophenyl functional group. Chemical producers typically introduce it in a controlled condensation phase during the installation of the active isoxazole moiety, ensuring high selectivity and purity for further transformation toward active pharmaceutical ingredients (APIs).

Industry compliance standards

• EU GMP Part II (Active Substances)
• US FDA 21 CFR Part 211
• ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• Ph. Eur. monographs on nonsteroidal anti-inflammatory agents

Typical usage ratio

• 0.9 – 1.2 mol equivalents per API synthesis batch, adjusted based on targeted yield and impurity control strategy

Downstream process integration

• Entry during the final condensation step with amino precursors under controlled temperature and inert atmosphere, followed by aqueous workup and purification for conversion to API bulk crystals

Final product types

• Bulk nonsteroidal anti-inflammatory tablet APIs (e.g., isoxazole-based)
• Pharmaceutical intermediate compounds exported for custom drug manufacturing

2. Isoxazole Fungicide Intermediate Production

Active ingredient manufacturers employ this acyl chloride as a core building block in the synthesis of select dicloro-phenyl isoxazole fungicides for cereal and vegetable crops. Its introduction is tightly controlled, and downstream integration occurs via nucleophilic addition to construct key ring structures essential for pesticidal activity.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• FAO/WHO Specification Guidelines for Agricultural Pesticides
• China GB 2763-2022: Maximum Residue Limits for Pesticides
• REACH Regulation (EC) No 1907/2006

Typical usage ratio

• 1.0 – 1.05 molar equivalents per fungicide synthetic sequence, precision based on stoichiometry and downstream chlorination demand

Downstream process integration

• Dosed during key cyclization phase with selective nucleophilic reagents, followed by purification via distillation or crystallization before formulation into technical-grade actives

Final product types

• Technical concentrate of isoxazole fungicides
• Processed pesticide formulations (suspension concentrates, granules, wettable powders)

3. Pharmaceutical Intermediate for Isoxazole-Based Antibacterial Drug Synthesis

This intermediate serves as a core structural contributor for antibacterial agents requiring dichlorinated phenyl-isoxazole substituents. In such pathways, downstream manufacturers inject the acyl chloride during the late-stage coupling process to establish the isoxazole pharmacophore, critical for the agent’s biological profile.

Industry compliance standards

• US Pharmacopeia (USP) monographs on antibacterial substances
• Japanese Pharmaceutical Excipients (JPE)
• WHO Pharmaceutical Production Quality Assurance Guidelines
• ISO 9001:2015 for pharmaceutical intermediate plants

Typical usage ratio

• 0.95 – 1.1 equivalents per batch, with modulations based on in-process control of side product formation

Downstream process integration

• Executed via acylation with secondary amines or other nucleophiles, followed by workup, crystallization, and filtration prior to stepwise conversion to finished antibiotic active

Final product types

• Sterile or non-sterile antibacterial bulk actives
• Intermediates for further process towards injectables or oral dose forms

4. Synthetic Route Intermediate in Isoxazole Herbicide Manufacturing

Producers of selective herbicides rely on this compound as an intermediate to incorporate the dichlorophenyl motif into isoxazole frameworks via condensation reactions essential for target specificity against weed species. The process calls for stringent environmental and safety controls due to the nature of the acyl chloride group and its reactivity in downstream scaling.

Industry compliance standards

• ISO 17025:2017 chemical analysis accreditation
• Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
• EPA Registration Requirements (for US, 40 CFR 152)
• ECHA Guidance for Agrochemical Active Substance Registration

Typical usage ratio

• 1.0 equivalent per herbicide synthesis cycle, with minor variance implemented for impurity reduction or process yield optimization

Downstream process integration

• Introduced during nucleophilic substitution under basic or acid-catalyzed conditions, often followed by multistage purification prior to formulation blending

Final product types

• Herbicide technical actives in concentrated solution or powder form
• Commercial herbicide blends (emulsifiable concentrates, granules)